1.
|
2024
|
論文
|
Disproportionality analysis of stomatitis associated with anticancer drugs using Japanese Adverse Drug Event Reporting Database accept for publication (共著)
|
2.
|
2023/09
|
著書
|
一緒にトレーニング! 薬剤師・薬学生のためのEBM活用法と論文の読み方(編集・上田 昌宏) (共著)
|
3.
|
2023/09
|
論文
|
Adverse Event Profile of Azacitidine: Analysis by Route of Administration using Japanese Pharmacovigilance Database Oncology Online ahead of print. (共著)
|
4.
|
2023
|
論文
|
Safety and blood levels of daratumumab after switching from intravenous to subcutaneous administration in patients with multiple myeloma Investigational New Drugs accept for publication (共著)
|
5.
|
2023
|
論文
|
Evaluation of time to onset and outcome of lung adverse events related to pembrolizumab using marketing surveillance Oncology Online ahead of print. (共著)
|
6.
|
2023
|
論文
|
Evaluation of time to onset and outcome of cardiac adverse events associated with nilotinib using post-marketing surveillance Oncology Online ahead of print. (共著)
|
7.
|
2023/06
|
論文
|
Evaluation of cardiac adverse events with ponatinib using a spontaneous reporting database Oncology 101(6),pp.397-405 (共著)
|
8.
|
2023/05
|
論文
|
Cardiac Adverse Events Associated with Multiple Myeloma Patients Treated with Proteasome Inhibitors Oncology 101(5),pp.343-348 (共著)
|
9.
|
2023/05
|
論文
|
Effect of blonanserin on the proliferation and migration of glioblastoma cells Pharmazie 78(5),pp.37-41 (共著)
|
10.
|
2023/05
|
論文
|
Evaluation of lung adverse events with nivolumab using the spontaneous reporting system in Japan Sci. Rep. 13(1),pp.8819 (共著)
|
11.
|
2023/05
|
論文
|
Evaluation of the time to onset and outcome of lenalidomide-induced thrombosis and embolism using spontaneous reporting database In Vivo 37(3),pp.1246-152 (共著)
|
12.
|
2023/03
|
論文
|
A survey of pharmacy students' satisfaction with a basic life support course and an exploration of factors related to awareness change before and after the course YAKUGAKU ZASSHI 143(3),pp.309-316 (共著)
|
13.
|
2023/03
|
論文
|
Assessment of Time-to-onset and Outcome of Lung Adverse Events With Pomalidomide from a Pharmacovigilance Study In Vivo 37(2),pp.955-961 (共著)
|
14.
|
2023/03
|
論文
|
Evaluation of cardiac adverse events with nivolumab using a Japanese real-world database Clin Drug Investig. 43(3),pp.177-184 (共著)
|
15.
|
2023/01
|
論文
|
The Influence of the Rapid Increase in the Number of Adverse Event Reports for COVID-19 Vaccine on the Disproportionality Analysis Using JADER In Vivo 37(1),pp.345-356 (共著)
|
16.
|
2022/12
|
論文
|
Evaluation of Lung Toxicity With Lenalidomide Using the Pharmacovigilance Database Anticancer Res. 42(1),pp.5917-5925 (共著)
|
17.
|
2022/12
|
論文
|
がん患者の便秘治療薬アカデミックディテーリング~基礎と臨床のエビデンスを活用した資材開発~ 医薬品安全性学 8(2),89-108頁 (共著)
|
18.
|
2022/11
|
著書
|
第VII章 物理・化学・環境 [化学] 13. 酸素 人間の許容・適応限界事典 468-471頁 (共著)
|
19.
|
2022/10
|
著書
|
がん支持医療テキストブック サポーティブケアとサバイバーシップ がん支持医療テキストブック サポーティブケアとサバイバーシップ (共著)
|
20.
|
2022/10
|
論文
|
Lack of clinical evidence of antiviral therapy for human monkeypox: a scoping review J Infect Chemother. pp.in press (共著)
|
21.
|
2022/09
|
論文
|
Evaluation of lung toxicity with bevacizumab using the spontaneous reporting database Sci.Rep. 12,pp.15619 (共著)
|
22.
|
2022/08
|
論文
|
Comprehensive analysis of adverse events induced by PARP inhibitors using JADER and time to onset. Life 12(9),pp.1355 (共著)
|
23.
|
2022/07
|
論文
|
Evaluation of lung adverse events with trastuzumab using the Japanese pharmacovigilance database. Medical Oncology 39,pp.219 (共著)
|
24.
|
2022/06
|
論文
|
Evaluation of Durvalumab-induced Lung Toxicity Using a Spontaneous Reporting Database. Anticancer Res. 42,pp.3575-3582 (共著)
|
25.
|
2022/06
|
論文
|
Evaluation of lung toxicity related to the treatment with alectinib using a pharmacovigilance database. Anticancer Res 42(6),pp.3109-3116 (共著)
|
26.
|
2022/05
|
論文
|
Comprehensive analysis of ixazomib-induced adverse events using the Japanese pharmacovigilance database. Oncology 100,pp.413-418 (共著)
|
27.
|
2022/05
|
論文
|
Evidence-based medicine education using team-based learning for cross-grade sixth-year pharmacy students in Japan: A pilot study Japanese J Pharm Educ (薬学教育) 6,pp.on line (共著)
|
28.
|
2022/05
|
論文
|
Time to Onset of Bendamustine-associated Skin Damage Using the Spontaneous Reporting System Anticancer Res. 42(5),pp.2737-2741 (共著)
|
29.
|
2022/05
|
論文
|
チーム基盤型学習と実習を組み合わせた臨床事前学習の試みとその評価 薬学教育 6,on line頁 (共著)
|
30.
|
2022/03
|
論文
|
Comprehensive analysis of everlorimus-induced adverse events using the Japanese real-world database J Clin Pharm Ther 47,1173-1180頁 (共著)
|
31.
|
2022/03
|
論文
|
薬学部4年生を対象としたEBMの実践を学ぶためのTBL&PBLハイブリッド学習プログラムの試行と評価 東京薬科大学研究紀要 25,27-34頁 (共著)
|
32.
|
2022/02
|
論文
|
Comprehensive analysis of bortezomib-induced adverse events using the Japanese real-world database Oncology 2022(100),pp.188-193 (共著)
|
33.
|
2022/02
|
論文
|
兵庫医療大学薬学部における基礎と臨床の橋渡し教育 薬学教育 6,on line頁 (単著)
|
34.
|
2022/01
|
論文
|
Evaluation of cardiac adverse events associated with carfilzomib using a Japanese real-world database Oncology 100,pp.60-64 (共著)
|
35.
|
2021/12
|
著書
|
できる薬剤師とよばれるために 上手に使いたい薬学ナレッジ101 (共著)
|
36.
|
2021/08
|
論文
|
日本人がん疼痛患者におけるメサドンの血中濃度測定および早期効果判定の可能性に関する検討 Palliative Care Research 16(3),231-239頁 (共著)
|
37.
|
2021/05
|
論文
|
病院薬剤師を対象とした簡易懸濁法研修会による認知度および意識変容に関する解析 社会薬学 40(1),50-58頁 (共著)
|
38.
|
2021/04
|
論文
|
教育コンピテンシーの全国測定を目指す~大学横断的な教育成果の研究プロジェクト~ 薬学教育 5,2021-012頁 (共著)
|
39.
|
2021/03
|
論文
|
withコロナ下におけるオープンソースを活用した有機化学および医薬品化学遠隔授業の試み 薬学教育 5,2020-054頁 (共著)
|
40.
|
2021/03
|
論文
|
テキストマイニングを用いたアンケート解析 薬学教育 5,jjphe.2020-009頁 (共著)
|
41.
|
2021/03
|
論文
|
物理系薬学実習におけるレポートルーブリックおよびピア評価導入の試み 薬学教育 5,jjphe.2020-068頁 (共著)
|
42.
|
2021/02
|
論文
|
ZOOMを活用した薬学実務実習における病院・薬局・大学合同オンライン症例解析報告会の実施とその評価 薬学教育 5,jjphe.2020-064頁 (共著)
|
43.
|
2020/12
|
論文
|
薬学実務実習における薬局・病院合同処方解析教育プログラムの導入とその評価 薬学教育 4,jjphe.2020-033頁 (共著)
|
44.
|
2020/08
|
論文
|
薬学部初年次学生に対する基礎有機化学と臨床をつなぐチーム基盤型学習のデザインと評価 リメディアル教育研究 14,29-37頁 (共著)
|
45.
|
2020/04
|
論文
|
薬学生を対象としたチーム基盤型学習による EBM 教育~兵庫医療大学における取り組み~ 薬学教育 4 (共著)
|
46.
|
2020/02
|
論文
|
薬学生を対象としたEBM教育におけるチーム基盤型学習の導入とその評価 薬学教育 140(2),301-312頁 (共著)
|
47.
|
2020/01
|
論文
|
Identification of HUHS190, a human naftopidil metabolite, as a novel anti-bladder cancer drug Bioorg. Med. Chem. Lett. 30(1),pp.126744 (共著)
|
48.
|
2019/12
|
論文
|
システマティックレビュー論文の評価と活用に向けたワークショップの実践とその評価 薬学教育 3 (共著)
|
49.
|
2019/07
|
論文
|
Development of a Water-Soluble Indolylmaleimide Derivative IM-93 Showing Dual Inhibition of Ferroptosis and NETosis. ACS Med Chem Lett. 10(9),pp.1272-1278 (共著)
|
50.
|
2018/12
|
論文
|
薬学部初年次数学系専門基礎科目と連動した少人数制補完教育の実践とその評価 兵庫医療大学紀要 6(2),1-8頁 (共著)
|
51.
|
2018/12
|
論文
|
薬剤師生涯教育としての「化学構造式ワークショップ」の試みとその評価 兵庫医療大学紀要 6(2),9-16頁 (共著)
|
52.
|
2018/08
|
論文
|
基礎系教員と実務家教員の連携による実務実習事前学習の試みとその評価 薬学教育 2,on line頁 (共著)
|
53.
|
2018/08
|
論文
|
薬学部3年次学生に対するEvidence-based Medicine (EBM)教育の試みとその評価 薬学教育 2,on line頁 (共著)
|
54.
|
2018/08
|
論文
|
薬剤師を対象とした化学構造式研修の取り組みと研修後アンケート調査 薬学雑誌 138(8),1085-1093頁 (共著)
|
55.
|
2018/05
|
論文
|
薬剤師・薬学生を対象とした実践的Evidence-based Medicine(EBM)教育の試み 薬学雑誌 138(5),655-666頁 (共著)
|
56.
|
2018/02
|
論文
|
Indolylmaleimide Derivative IM-17 Shows Cardioprotective Effects in Ischemia-Reperfusion Injury. ACS Med. Chem. Lett 9,pp.182-187 (共著)
|
57.
|
2018/02
|
その他
|
「臨床貢献」を目指す基礎&薬学教育研究 兵薬界 (2) (単著)
|
58.
|
2018/01
|
論文
|
Metabolically Stable PCA-1/ALKBH3 Inhibitor Has Potent Antiprlliferative Effects on DU145 Cells In Vivo. Anticancer Res. 38,pp.211-218 (共著)
|
59.
|
2017/12
|
論文
|
1年次有機化学系科目における授業連携型学習支援の実施とその評価 兵庫医療大学紀要 5(2),1-9頁 (共著)
|
60.
|
2017/08
|
論文
|
薬剤師・薬学生を対象とした実践的Evidence-based Medicine(EBM)教育の試みとその評価 薬学雑誌 137(8),987-998頁 (共著)
|
61.
|
2017/07
|
論文
|
Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor. Bioorg. Med. Chem. Lett. 27(14),pp.3167-3172 (共著)
|
62.
|
2017/06
|
その他
|
糖尿病の薬のカタチを楽しもう~構造式≠有機化学の世界にようこそ~ くすりと糖尿病 6(1),9-16頁 (単著)
|
63.
|
2017/04
|
論文
|
Systematic Trial for Evaluating Docetaxel in a Human Prostate Cancer Cell DU145 Xenograft Model. Anticancer Res. 37,pp.1665-1676 (共著)
|
64.
|
2016/08
|
論文
|
Structure-Activity Relationship Study of 3-Amino-2-indolyllactam Derivatives: Development of Inhibitors of Oxidative Stress-Induced Necrosis. Chem. Pharm. Bull. 64,pp.886-898 (共著)
|
65.
|
2016/06
|
論文
|
The phosphatidylethanolamine derivative diDCP-LA-PE mimics intracellular insulin signaling. Sci. Rep. (共著)
|
66.
|
2016/01
|
論文
|
HUHS1015 Suppresses Colonic Cancer Growth by Inducing Necrosis and Apoptosis in Association with Mitochondrial Damage. Anticancer Res. 36,pp.39-48 (共著)
|
67.
|
2016/01
|
その他
|
薬のカタチを楽しもう 兵庫県病院薬剤師会会報 147,8-11頁 (単著)
|
68.
|
2015/12
|
論文
|
Phosphatidylinositol Derivatives Induce Gastric Cancer Cell Apoptosis by Accumulating AIF and AMID in the Nucleus. Anticancer Res. 35(12),pp.6563-6571 (共著)
|
69.
|
2015/12
|
論文
|
XIAP is a target for HUHS1015-induced cspase-3 activation in CW2 colonic cancer cells. International Journal of Biological & Pharmaceutical Research 6(12),pp.978-981 (共著)
|
70.
|
2015/10
|
論文
|
HUHS1015 Induces Apoptosis of MKN45 Gastric Cancer Cells by Activating Caspase-3 in Association with Mitochondrial Damage. International Journal of Biological & Pharmaceutical Research 6(10),pp.771-775 (共著)
|
71.
|
2015/09
|
論文
|
Phosphatidylinositol derivative enantiomers have the different potential for the antitumor effect against maligrant pleural mesothelioma cells. International Journal of Biological & Pharmaceutical Research 6,pp.731-733 (共著)
|
72.
|
2015/08
|
論文
|
DCP-LA Activates Cytosolic PKCε by Interacting with the Phosphatidylserine Binding/Associating Sites Arg50 and Ile89 in the C2-Like Domain. Cell. Physiol. Biochem. 39,193-200頁 (共著)
|
73.
|
2015/08
|
論文
|
Identification and purification of target protein using affinity resin bearing a photo-labile linker. Bioorg. Med. Chem. Lett. 25(16),pp.3373-3377 (共著)
|
74.
|
2015/08
|
論文
|
Phosphatidylinositol derivative enantiomers have the different potential for the antitumor effect against maligrant pleural mesothelioma cells International Journal of Biological & Pharmaceutical Research. 6,pp.731-733 (共著)
|
75.
|
2015/08
|
論文
|
Rac1 and ROCK are implicated in the cell surface delivery of GLUT4 under the control of the insulin signal mimetic diDCP-LA-PE. J. Pharmacol. Sci. 128,pp.179-184 (共著)
|
76.
|
2015/07
|
論文
|
Improvement of solid material for affinity resins by application of long PEG spacers to capture the whole target complex of FK506. Bioorg. Med. Chem. Lett. 25(14),pp.2788-2792 (共著)
|
77.
|
2015/03
|
論文
|
The newly synthesized anticancer drug HUHS1015 is useful for treatment of human gastric cancer. Cancer Chemother Pharmacol. 75,pp.527-535 (共著)
|
78.
|
2015/02
|
論文
|
アフィニティ樹脂を用いた生理活性物質のターゲット探索 -化学的に安定で非特異的タンパク質吸着が少ない汎用的固相担体AquaFirmus™開発- MEDCHEM NEWS 25(1),38-44頁 (共著)
|
79.
|
2015/01
|
論文
|
Improving the Bioavailability and Anticancer Effect of the PCA-1/ALKBH3 Inhibitor HUHS015 Using Sodium Salt In vivo 29,pp.39-43 (共著)
|
80.
|
2014/12
|
論文
|
1-[2-(2-Methoxyphenylamino)ethylamino]-3-(naphthalene-1-yloxy)propan-2-ol may be a promising anticancer drug. Molecules 19,pp.21462-21472 (共著)
|
81.
|
2014/07
|
論文
|
Newly synthesized anticancer drug HUHS1015 is effective on malignant pleural mesothelioma. Cancer Sci. 105,pp.883-889 (共著)
|
82.
|
2014/04
|
論文
|
PTP1B inhibition causes Rac1 activation by enhancing receptor tyrosine kinase signaling. Cell. Physiol. Biochem. 33,pp.1097-1105 (共著)
|
83.
|
2014/02
|
論文
|
A novel PP2A enhancer induces caspase-independent apoptosis of MKN28 gastric cancer cells with high MEK activity. Cancer Lett. 347,pp.123-128 (共著)
|
84.
|
2014/01
|
論文
|
DCP-LA-Phosphatidylinositol and Its Enantiomer Exhibit Different Bioactivities. Cell. Physiol. Biochem. 33,pp.300-309 (共著)
|
85.
|
2014/01
|
論文
|
Design and synthesis of prostate cancer antigen-1 (PCA-1/ALKBH3) inhibitors as anti-prostate cancer drugs. Bioorg. Med. Chem. Lett. 24,pp.1071-1074 (共著)
|
86.
|
2014/01
|
論文
|
Synthesis of 1-acetyl-2-silyoxycycloheptane derivatives via highly stereoselective formal [5+2] cycloaddition reaction. Tetarahedron Lett. 55,pp.1192-1195 (共著)
|
87.
|
2013/06
|
論文
|
1-[2-(2-Methoxyphenylamino)ethylamino]-3-(naphthalene-1-yloxy)propan-2-ol as a potential anticancer drug Pharmacology 91,pp.339-345 (共著)
|
88.
|
2013/04
|
論文
|
Effects of Newly synthesized DCP-LA-phospholipids on protein kinase C and protein phospatases Cell. Physiol. Biochem. 31,pp.555-564 (共著)
|
89.
|
2013/01
|
論文
|
Regulation of GluA1 AMPA Receptor through PKC Phosphorylation Induced by Free Fatty Acid Derivative HUHS2002 Lipids 48,pp.23-28 (共著)
|
90.
|
2012/09
|
論文
|
Indomethacin Serves as a Potential Inhibitor of Protein Phosphatases. Cell. Physiol. Biochem. 30,pp.1014-1022 (共著)
|
91.
|
2012/07
|
論文
|
Novel Indomethacin Action: Selective and Direct Activation of Protein Kinase C-e Cell Physiol. Biochem. (共著)
|
92.
|
2012/06
|
論文
|
Free Fatty Acid Derivative HUHS2002 Potentiates a7 ACh Receptor Responses Through Indirect Activation of CaMKII Lipids 47 (共著)
|
93.
|
2012/05
|
論文
|
8-[2-(2-Pentyl-Cyclopropylmethyl)-Cyclopropyl]-Octanoic Acid and Its DIastereomers Improve Age-Related Cognitive Deteriotation Lipids 47,pp.687-695 (共著)
|
94.
|
2012/04
|
論文
|
Synthetic Route to Optically Pure Norcantharidin Analog NCA-01, a Highly Selective Protein Phosphatase 2B Inhibitor, and Its Derivatives Chem. Asian. J. On Line (共著)
|
95.
|
2012/01
|
論文
|
Indomethacin Enhances Learning and Memory Potential by Interacting with CaMKII Journal of Cellular Physiology 227(3),pp.919-926 (共著)
|
96.
|
2011/03
|
論文
|
Formal [6+4] cycloaddition of a dicobalt acetylene complex with furan derivatives Teterahedron Lett. 52,pp.910-912 (共著)
|
97.
|
2011/03
|
論文
|
α,β-DCP-LA Selectivity Activates PKC-ε and Stimulates Neurotransmitter Release with the Highest Potency among 4 Diastereomers Cellular Physiology and Biochemistry 27,149-158頁 (共著)
|
98.
|
2010/11
|
論文
|
Selective elution of target protein from affinity resins by a simple reductant with a thiol group Bioorg. Med. Chem. Lett. 20,pp.7361-7364 (共著)
|
99.
|
2010/05
|
論文
|
Total synthesis of furanether B. Construction of a hydroazulene skeleton via a novel [5 + 2] cycloaddition reaction of silyloxyallene Chem. Lett. 39,pp.630-632 (共著)
|
100.
|
2010/03
|
論文
|
Cyclooctanone synthesis via a formal [6+2] cycloaddition reaction of a dicobalt acetylene complex Teterahedron Lett. 51,pp.3983-3986 (共著)
|
101.
|
2009/10
|
論文
|
Asymmetric synthesis of isobenzofuranone derivatives and their unique character as protein kinase Cα (PKCα) Teterahedron Lett. 50,3609-3612頁 (共著)
|
102.
|
2009/03
|
論文
|
Improvement of monolithic solid material by utilization of spacer for identification of the target using affinity resins Bioorg. Med. Chem. Lett. 19,pp.1469-1472 (共著)
|
103.
|
2007/09
|
論文
|
Importance of interaction between C1 domain and lipids in protein kinase Cα activation: Hydrophobic side chain direction in isobenzofuranone ligands controls enzyme activation level ChemMedChem 2,1006-1009頁 (共著)
|
104.
|
2006/05
|
論文
|
プロテインキナーゼC(PKC)の構造と活性化機構の解明を目指した新規C1ドメインリガンドの創製 有機合成化学協会誌 2006(64),515-528頁 (共著)
|
105.
|
2005/05
|
論文
|
Inhibition of hydrogen peroxide-induced necrotic cell death with 3-amino-2-indolylmaleimide derivatives Bioorg. Med. Chem. Lett. 15,pp.3114-3118 (共著)
|
106.
|
2005/03
|
論文
|
An efficient catalytic enantioselective fluorination of β-ketophosphonates using chrial palladium complexes Teterahedron Lett. 46,pp.1447-1450 (共著)
|
107.
|
2002/06
|
論文
|
Stereoselective Synthesis of Cycloheptanone Derivatives via an Intermolecular [5+2] Cycloaddition Reaction Org. Lett 4,pp.2217-2219 (共著)
|
108.
|
2000/05
|
論文
|
A Novel [5+2] Cycloaddition Reaction Using a Dicobalt Acetylene Complex J. Am. Chem. Soc. 122,pp.6116-6117 (共著)
|
109.
|
2000/04
|
論文
|
An intramolecular hetero Diels-Alder reaction of α-(alkynylsiloxy)aldimine derivatives. Teterahedron Lett. 41,pp.5715-5718 (共著)
|
110.
|
1998/03
|
論文
|
A Novel Method for Inside Selective Silylation of 1,2-Diols. J. Org. Chem. 63,pp.2422-2423 (共著)
|
5件表示
|
全件表示(110件)
|